Navigation Links
Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
Date:1/16/2008

mmatory drug target. At the same time, they also protect cells and tissues against inflammatory damage. Morria is determined to become a pivotal player in the anti-inflammatory drug market by developing and commercializing novel drugs for acute pulmonary and gastro-intestinal inflammatory diseases. For more information, please visit http://www.morria.com.

This is not an invitation nor is it an offer to purchase or subscribe for shares. This release is only intended for persons falling within the exception set out in regulation 47 of the Financial Promotion order -- Persons in the business of disseminating information.

Contact:

Meghan Feeks

+1-212-827-0020

mfeeks@rlcinc.com


'/>"/>
SOURCE Morria Biopharmaceuticals Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
4. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
5. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... Omega-3 therapies for cardiovascular disease and overall health, announced ... shares of the Corporation (the "Common Shares"). The Common ... December 5 th , 2014 to March 4 th ... due on or before April 1, 2015. Interest on ...
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
(Date:3/26/2015)... , March 26, 2015  CCS Medical ... home medical supplies for patients with chronic conditions, ... and Chief Executive Officer, effective March 23.  Mr. ... telehealth company, where he was President of Operations. ... was President and Executive Vice President of Operations ...
Breaking Medicine Technology:Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2
... 8, 2011 Allied Healthcare Products, Inc. (NASDAQ: AHPI ... in sales. Allied,s net loss for the first quarter ... 2 cents per basic and diluted share, versus a loss of ... previous year,s first quarter. Allied,s sales for the quarter ...
... 8, 2011 FDA approved Makena (hydroxyprogesterone caproate) in ... certain preterm births in women who have had at ... Makena was approved, a version of the active ingredient ... requested the drug from a pharmacist who compounded the ...
Cached Medicine Technology:Allied Healthcare Products Reports First Quarter Loss on Sales Decline 2Allied Healthcare Products Reports First Quarter Loss on Sales Decline 3Allied Healthcare Products Reports First Quarter Loss on Sales Decline 4FDA Statement on Makena 2
(Date:3/26/2015)... March 26, 2015 Let’s not lose ... Fresh produce are today’s traffic magnets. Three out of ... because of their produce department, according to a Packaged ... as people are looking to add more fruits and ... Produce Manager® Day is April 2. As featured in ...
(Date:3/26/2015)... Francisco, CA (PRWEB) March 26, 2015 The ... These will be on the topics of the DAOM Program ... The DAOM Program Overview Webinar will be hosted by Dr. ... and provide the next steps on how to prepare for ... 12:30 p.m. March 25, March 27, April 1 and April ...
(Date:3/26/2015)... 26, 2015 Building off their ... medical education, the Cardiometabolic Risk Summit ... Tulane University are proud to announce a ... The interdisciplinary program , which ultimately grants ... designed for physicians, nurse practitioners, physician assistants, registered ...
(Date:3/26/2015)... 26, 2015 U.S. medical real ... in 2014, according to an exclusive new report ... healthcare real estate (HRE) data firm also announced ... two new Gold-Level Partners: Harrison Street Real Estate ... MOB transactions still going strong, yields compressed, prices ...
(Date:3/26/2015)... March 26, 2015 BioPlus ... leading innovative specialty pharmacies, announces the promotion of ... Vice President of Pharmaceutical Relations. In this position, ... with our pharmaceuticals partners and providing key leadership ... of BioPlus’ expansion. , “Over the past ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming Webinars 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... Site at: http://www.mariestopes.org.uk/sexbomb , Marie Stopes International ... Sex Bomb campaign to discover what sex and,relationships mean ... century., The Sex Bomb is a specially designed ... that truly capture a snapshot,of the sex lives and ...
... SAN DIEGO, Sept. 16 SpectraScience, Inc. (OTC,Bulletin Board: ... it is shipping its WavSTAT(R) Optical Biopsy System to ... Diego/VA to complete a,study at each site. The purpose ... the Optical Biopsy System as an adjunctive tool to,improve ...
... 16 Sugarman, Rogers, Barshak & Cohen,P.C. announced ... lawsuits,against Canadian company Wellnx Life Sciences, which markets ... and against its,owners and senior managers, Derek Woodgate, ... pending in federal courts and consolidated in U.S.,District ...
... The National,Autism Association announced today that ... recipients of Project Lifesaver funding through the,organization,s ... the rise in,wandering-related deaths among children with ... tracking program established to,quickly locate and rescue ...
... prestigious awards for excellence in medical advertising and medical commercials, ... the 25th Annual Healthcare Marketing Report Healthcare Advertising Awards. ... ... 2008 -- http://www.healthcaresuccess.com [Medical advertising agency Healthcare Success ...
... collagen in skin that has never been exposed , , TUESDAY, Sept. ... skin, but only if that skin has never been touched by ... Decades of sun damage on the face and arms and other ... to a study in the September issue of the Archives ...
Cached Medicine News:Health News:Sex Bomb - What Really Turns Us On in the Naughty 'Noughties'? 2Health News:SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients 2Health News:SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients 3Health News:Canadian Company Sued for Defrauding Thousands of U.S. Consumers of Dietary Supplements 2Health News:National Autism Association's 'FOUND' Provides Funds to Union County Sheriff's Office for Project Lifesaver Equipment 2Health News:Medical Advertising Agency Healthcare Success Strategies Wins Two Gold Awards 2Health News:Estrogen Cream No Match for Sun-Damaged Skin 2
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
... arthroplasty has proven to be a ... and total knee arthroplasty with proper ... minimally invasive unicompartmental knee system developed ... Using the latest conservative surgical techniques ...
... System offers a femoral option and tibial ... action that engages at 60 degrees of ... roll-back motion and allow for 130 degrees ... conjunction with the femur is designed to ...
... Sigma Total Knee System is designed to ... a variety of clinical indications. Based on ... introduced in 1984, P.F.C. Sigma continues a ... substitution is required for the posterior cruciate ...
Medicine Products: